- Home
- ONEG vs CCCC Comparison
ONEG vs CCCC Comparison
Compare ONEG & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- CCCC
- Stock Information
- Founded
- ONEG 2021
- CCCC 2015
- Country
- ONEG Hong Kong
- CCCC United States
- Employees
- ONEG 26
- CCCC N/A
- Industry
- ONEG Homebuilding
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- ONEG Consumer Discretionary
- CCCC Health Care
- Exchange
- ONEG Nasdaq
- CCCC Nasdaq
- Market Cap
- ONEG 181.8M
- CCCC 175.1M
- IPO Year
- ONEG 2024
- CCCC 2020
- Fundamental
- Price
- ONEG $11.42
- CCCC $2.23
- Analyst Decision
- ONEG
- CCCC Strong Buy
- Analyst Count
- ONEG 0
- CCCC 4
- Target Price
- ONEG N/A
- CCCC $8.50
- AVG Volume (30 Days)
- ONEG 260.4K
- CCCC 1.8M
- Earning Date
- ONEG 01-01-0001
- CCCC 10-30-2025
- Dividend Yield
- ONEG N/A
- CCCC N/A
- EPS Growth
- ONEG N/A
- CCCC N/A
- EPS
- ONEG 0.08
- CCCC N/A
- Revenue
- ONEG $53,205,000.00
- CCCC $34,240,000.00
- Revenue This Year
- ONEG N/A
- CCCC N/A
- Revenue Next Year
- ONEG N/A
- CCCC N/A
- P/E Ratio
- ONEG $147.84
- CCCC N/A
- Revenue Growth
- ONEG N/A
- CCCC 16.55
- 52 Week Low
- ONEG $1.48
- CCCC $1.09
- 52 Week High
- ONEG $13.50
- CCCC $7.14
- Technical
- Relative Strength Index (RSI)
- ONEG 52.74
- CCCC 38.86
- Support Level
- ONEG $10.08
- CCCC $2.13
- Resistance Level
- ONEG $11.82
- CCCC $3.43
- Average True Range (ATR)
- ONEG 0.86
- CCCC 0.30
- MACD
- ONEG -0.31
- CCCC -0.12
- Stochastic Oscillator
- ONEG 42.25
- CCCC 6.91
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.